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ABSTRACT
Exploring Concentration and Duration Dependence in Hormesis
Maren S. Prediger
The phenomenon of hormesis, characterized by beneficial low-exposure stress-protective effects,
has experienced increasing interest by the scientific community. Elucidating the underlying
cellular signaling pathways that lead to a new homeostatic state can provide crucial information
about new therapeutic targets to prevent and treat diseases. Commonly investigated for hormetic
behavior are plant-based substances (phytochemicals), such as quercetin, epigallocatechin gallate,
curcumin, and resveratrol. The polyphenol resveratrol, found in peanuts, grapes, and subsequently
in wine, is known for a variety of effects - beneficial and detrimental - depending on the
investigated cell type and concentration. In HepG2 cells, an increase in proliferation has been
observed previously at doses between 10 µM to 100 µM after 16 hours, while higher doses
decreased cell viability markedly, eventually leading to cell death. For other compounds, literature
searches provide conflicting data on the hormetic capabilities and subsequently on the associated
concentrations. This work aims to clarify the concentration and exposure duration dependence in
hormesis. The four aforementioned compounds were screened for their hormetic behavior in a
human liver cancer model by assessing the effects of varying concentrations on metabolic activity
and plasma membrane integrity. Quercetin, epigallocatechin gallate, and curcumin did not show
hormetic properties in the investigated concentration range during a 24-hour exposure. Resveratrol
qualified for further experiments where cells were subjected to 0.1 to 500 µM for six, twelve, 24,
48, and 72 hours. A significant change in metabolic activity at concentrations of 50, 100, and
250 µM was found between twelve and 24 hours, as well as a significant increase in plasma
membrane degradation after 24 hours at doses higher than 100 µM. This demonstrates a noticeable
change in cellular behavior between the twelve- and 24-hour mark, associated with resveratrol
concentrations from 50 to 250 µM. Future research should include real-time assessment of energy
markers, preferably up to 24 hours, to pinpoint timepoints of metabolic switches, and subsequently
study the changes that underlie hormesis at these timepoints.
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1. Introduction: Aspects of Cellular Signaling, Energy Demand, and
Hormesis

Multicellular organisms are in a constant fight of survival with the environment and everything
stands in exchange of matter and energy. It is a battle on two fronts: the physical environment,
which includes insults from sunlight, dryness, wind, storm, or cold, and the chemical environment,
represented by myriads of harmful and/or beneficial micro- and macromolecules.1,2 Every living
species on this planet, at any given moment in history up until now, has evolved and adapted to
the direct environment, in an effort to maximize the likelihood of survival and procreation.
Adaptions can be long lasting changes in the genetic sequence, or in its expression, that affect
subsequent generations, but often are transient changes to handle immediate exposures. On the
molecular and cellular level, this can be achieved by settling for a state of equilibrium, that is
different than the state before, particularly in hormesis.
The phenomenon of hormesis is commonly described as a biphasic dose-response behavior, where
low doses of a compound exert a beneficial effect on cells or tissue, while higher doses prove
detrimental.3–6 More broadly, it can also be stated with the familiar saying: “what does not kill
you, makes you stronger”. Rigorous exercise and simultaneous energy restriction have long been
seen as the original trigger for hormesis, based on a switch between “stress resistance mode” and
“growth/plasticity mode”1. Short periods of ischemia also appear to “precondition” the heart for a
more severe ischemic event.7 However, the principle of hormesis has already been described in
the late 19th century by Prof. Hugo Schulz, when he observed stimulation of bacterial metabolism
through bactericidal agents at low doses.8 The underlying concept of small amounts of injury
strengthening the system in the long run has been attributed to the effects on receptor signaling,
signaling pathways such as the mammalian (mechanistic) Target of Rapamycin, and cellular
antioxidant systems.4,8,9 Theories on how constant low-level stress can be beneficial include two
aspects: an increase in repair behavior, and an adaption towards a more stress-resistant state within
the cell. In the early years of hormesis research, studies focused on toxic substances, including
metals, but the scope of a “mild stressor” has been broadened to include environmental stimuli as
well, especially plant-based substances.4,7 Generally, a hormetic effect is attributed to a stressor,
may it be of physical, nutritional, or environmental origin, when the dose-response assessment has
1

biphasic character (inverted U- or J-/U- shaped curves).10,11 These curves display a hormetic zone,
where the associated dose stimulates the assay response up to 30 - 60% of the control
(significantly, especially with respect to the physiological consequences).8,10 Figure 1 shows
exemplary curves if one were to measure cell viability and cell death in a dose-dependent manner:
The hormetic zone is then defined as the area where a decrease in cell death to a percentage less
than the control value or an increase in cell viability above control values is observed.
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Figure 1| Stylized curves illustrating a dose-response curve that shows hormetic behavior.
On the left, a U-shaped curve as it would ideally be found when measuring cell death, for example. On the right, an
inverted U-shaped curve, as it would ideally be found when measuring cell viability, for example.

To assess, understand, take advantage of, or undo a compound’s effect on a system, it is necessary
to characterize the cellular signaling associated with the molecule. While it is important to know
how the molecule distributes throughout the system, e. g. where it is absorbed, stored, or
metabolized, it is even more important to detect the changes the molecule and its metabolites evoke
in the systems smallest unit, the cell, and the associated time course.12

1.1. Cellular Signaling: Function and Cellular Constituents Involved
A xenobiotic insult generates a variety of responses inside a cell, a whole machinery of different
mechanisms that deal with the foreign substance and its metabolites. A lot of these mechanisms
are evolutionary conserved and the entirety of the responses are termed the cell danger response
(CDR).2 For the machinery to deal with the xenobiotic successfully, all incorporated pathways
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need to communicate with each other across cellular compartments and membranes in signal
transduction.

1.1.1. Membranes
Lipophilic in nature, the cell membrane core establishes a very effective barrier between the
extracellular environment and the cytosol as well as between the cytosol and organelle matrices.
Only select molecules can diffuse freely through the semipermeable membranes, based on their
size and hydrophobicity. Passive diffusion through the membrane is possible for uncharged,
lipophilic molecules that “dissolve” in the membrane (e.g. steroid hormones derived from
cholesterol).13 Polar molecules and ions, except water, cannot freely cross the membrane due to
their lipophobic character. Many chemical species, such as metabolic products from carbohydrate
and protein metabolism, as well as electrolytes, and growth factors, must transfer in and out of
cells. Not every molecule needs to enter the cell, to communicate the environmental status quo.
Eukaryotic cells are well-equipped to sense signals outside of the cell, amplify them inside the
cell, and initiate an appropriate response. Membrane spanning sensor proteins, or receptor proteins,
which are present on cell and organelle membranes, are capable of binding a ligand on one side
(e.g. extracellular) and activating secondary messengers on the other side (e.g. in the cytosol). 14
They thereby propagate the signal into the cell. In return, the cell can signal its status quo to the
surrounding environment through lipid vesicles and exosomes, for example.

1.1.2. Signaling in the Mitochondria
The mitochondria has been recognized as a highly important organelle in cell signaling as it is
actively involved in apoptosis, autophagy, immune responses, and calcium signaling.15 These
functions are intimately interwoven: cell death in the form of apoptosis is considered the first-line
of defense against incoming pathogenic threats. At the same time, cell death initiates an immune
response to clear the pathogenic threat, which can be controlled through autophagy as a prosurvival mechanism.15 The mitochondria is, at the same time, considered the “powerhouse” of the
cell, due to its role in energy production in the form of adenosine triphosphate (ATP).
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As a side-effect of energy production in the mitochondria, reactive oxygen species (ROS) are
produced due to electrons leaking from the electron transport chain. Despite the overall harmful
effects of ROS on cellular molecules, recent research suggests a beneficial impact from low
concentrations of ROS. It is thought that these concentrations may stress the cell just enough to
cause adaption and prolong longevity instead of cell death,16 which might even decrease the pace
of aging. Ji et al. (2010), Sauer et al. (2001), and Linley et al. (2012) connect an increase in
hydrogen peroxide from immediate ROS detoxification, and ROS in general, to the enhanced
regulation of embryonic stem cell differentiation, intracellular cell growth, and neurokinin
signaling in sensory neurons, respectively.17–19

1.1.3. Temporal and Spatial Aspects of Signaling
A cell is prepared to respond to signals in various places, and the duration and ramification of the
signal vary significantly based on the nature of the stimulant. The duration of a signal depends on
the pathways involved, and cellular compartmentalization offers distinct locations for distinct
functions. Reaction kinetics and substrate availability also dictate the temporal aspect of signaling,
since some reactions take longer than others.12,20 Not every process occurs everywhere in the cell;
organelles have a specific microenvironment that increases the likelihood of certain reactions more
over others. The early pictures of linear signal pathways made way for complex signaling cascades
and networks, that can be highly conserved, such as signaling through cell cycle checkpoints, or
can be highly complex and even vary for the same signal molecule depending on the tissue type.
The basis of spatially distributed signals and reactions is a difference in diffusivity for
active/inactive forms of signaling molecules. While it is known that the activity of an enzyme
changes with posttranslational modification, the diffusivity also changes, creating separate
concentration gradients for the two forms of the same molecule. Additionally, due to slightly
changed physical properties, the preference in microenvironment can change, and therefore the
localization within the cell.21 For example, when a ligand binds to a G-protein coupled receptor
(GPCR) on the membrane surface, a kinase causes a secondary response right inside the
membrane. Through the secondary response molecule, another kinase more distant from the
membrane is activated, and so on and so forth. Signals are eventually terminated by phosphatases
in the cytosol, but not without branching into and initiating more signaling. 20 The exact location
4

of termination, closer or not so close to the membrane, depends on the strength (concentration) of
the original GPCR signal. The stronger the signal, the longer the transmission range inside the
cytosol and the more diverse pathways can theoretically be activated. This also ties into the
temporal aspect of signaling, since it will not take as long to activate a pathway close to the
membrane as it does when it is initiated somewhere in the cytosol, spatially further away from the
original signal. Another example is the initiation of apoptosis, where several pathways at several
locations (receptors, mitochondria, endoplasmic reticulum, etc.) can initiate a cascade of signals
that eventually seem to converge at the mitochondria and then start the cleavage of procaspases
inside the cytosol.22
1.2. Cellular Energy Requirement, Storage, and Metabolism
Cellular signaling is especially important to communicate the metabolic state of a cell within the
cell and to the environment. Intermediates in metabolic pathways are therefore also considered
signaling molecules and can import information. Metabolic processes are either of anabolic nature,
to build larger biomolecules from smaller parts, or of catabolic nature, to break down larger
biomolecules into smaller parts.23,24 Catabolic pathways release energy during their breakdown
reactions, while anabolic pathways require energy input in the biosynthesis of macromolecules.
The energy that was released or needed in these pathways is stored in highly energetic covalent
bonds such as phosphate esters and phosphoanhydride bonds found in ATP or nicotinamide
adenine dinucleotide phosphate (NADPH).23,25–27 Coupling of anabolic and catabolic processes
connects energy-requiring and energy-releasing reactions, which creates interrelated networks that
overall yield an increase in entropy.
In eukaryotic cells, several catabolic pathways cross, interact, feed into each other, and can
eventually all lead to the production of energetic resources (Figure 2).26 Detailed descriptions of
the metabolism of the three main macronutrients (carbohydrates, proteins, and lipids) can be found
in literature.23,25,27 Briefly, lipids are oxidized in a step-wise fashion via β-oxidation, yielding
acetyl-CoA, NADH and flavin adenine dinucleotide (FADH2), while carbohydrates – once broken
down into single glucose molecules – are metabolized in several pathways depending on the
availability of oxygen. The first part of glycolysis is universal, oxygen independent, and produces
two equivalents of pyruvate, ATP, and NADH. Anaerobic conditions lead to the fermentation of
pyruvate into lactate (oxidative process). Aerobic conditions lead to three consecutive pathways
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in the mitochondria. First, pyruvate is oxidized into acetyl-CoA while creating an equivalent of
NADH, then acetyl-CoA feeds into the citric acid cycle that yields three molecules of NADH and
one molecule of FADH2 per acetyl-CoA. Lastly, the energetic coenzymes participate in oxidative
phosphorylation in the electron transport chain to produce ATP directly. Proteins are primarily
broken down into their respective single amino acids, which are subsequently used for the
synthesis of peptides, but in times of energy demand they can feed into cellular respiration and
therefore can also serve as an energy resource.24

Figure 2| Overview of the converging pathways in carbohydrate, peptide, and lipid metabolism.

1.2.1. Redox Coenzymes: Nicotinamides and Flavins
Oxidation and reduction reactions are often catalyzed by enzymes that depend on redox
coenzymes,28 which transiently store released energy, mostly in the form of one or two
electrons.29,30 Two coenzymes families are important regarding energy metabolism: NAD+
(nicotinamide adenine dinucleotide) and flavins. The former is the precursor for NADP+
(nicotinamide adenine dinucleotide phosphate).31 Both are highly involved in cellular metabolism
as hydride-transfer enzymes, since they can take up two electrons and a proton to form their
reduced counterparts NADH and NADPH.31 The dephosphorylated form is of special interest in
this regard because it can efficiently cause the translocation of a proton at the inner mitochondrial
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membrane to establish the proton gradient that is the driving force for ATP production in oxidative
phosphorylation. Flavin adenine dinucleotide (FAD) on the other hand is capable of one and two
electron transitions, either sequentially or simultaneously.23 In the electron transport chain (ETC),
unpaired electrons from oxidized metabolites can be transferred to diatomic oxygen through
FADH2 (Figure 3).27

Figure 3| Overview of the electron transport chain and ATP synthase.
The schematic depicts the membrane-bound complexes I through IV and ATP synthase and their action in oxidative
phosphorylation: Complex I, III, and IV establish a proton gradient, while Complex II facilitates an electron
exchange that ultimately leads to the formation of water. ATP synthase phosphorylates ADP through the motive
force from the proton gradient.
Figure reprinted from: Figure 5, OpenStax. Carbohydrate Metabolism (OpenStax CNX, 2015). Download for free at
http://cnx.org/contents/9d68abf9-4c2e-4ef7-88d1-c963c5c844b9@4.

1.2.2. ATP
ATP is considered the energy currency of the biological metabolism.32 As Voet and Voet (2011)
state it:
“the cellular role of ATP is that of a free energy transmitter rather than a free
energy reservoir.” 23
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The key to its function lies in the three phosphate groups and the two covalent bonds between
them, that hold high potential energy. The first phosphate group attached to the nucleoside is bound
through a phosphate ester bond to the 5’ oxygen on the nucleoside’s ribose. The additional two
phosphate groups then form phosphoanhydride bonds to each other (α,β – and β,γ – linkages).27
The hydrolysis of one mol of ATP to adenosine diphosphate (ADP) has been calculated to release
7.3 kcal/mol under standard condition and 14 kcal/mol under cellular conditions (30.5 kJ/mol and
57 kJ/mol, respectively).23–25,27 Eukaryotic ATP is directly produced via two pathways: Firstly,
through oxidative phosphorylation in the mitochondria, where the membrane proteins of the
electron transport chain use the energy from electron carriers to establish a proton gradient in the
mitochondrial intermembrane space and couple protons to oxygen to form water (Figure 3). The
relief of the proton gradient through the peptide ATP synthase yields the sought-after energy-rich
nucleotide. The second pathways is glycolysis in the cytosol, which also releases ATP, but in
smaller quantities (two molecules per glucose).33 Other catabolic pathways indirectly lead to the
production of energetic adenosine as well, either by providing glucose, intermediates for the citric
acid cycle, or reduced electron carriers. The breakdown of ATP, to adenosine diphosphate and
adenosine monophosphate, fuels cellular processes that would otherwise be energetically
unfavorable. Additionally, some sources see ATP, ADP, and AMP as a stimulated extracellular
signaling molecule and neurotransmitter in purinergic signaling associated with the cell danger
response, especially in neuronal cells. Increased secreted ATP from stressed cells then inevitably
evokes an immune response.2

1.2.3. Metabolic Reprogramming in Cancer Cells
While most cells rely heavily on mitochondrial oxidative phosphorylation to produce ATP, it was
observed by Otto Warburg et al. at the beginning of the past century, that carcinoma cells turn over
glucose into lactose 125x more than blood, up to 200x more than an inactive frog leg muscle, and
8x more than an active frog leg muscle at its maximum capacity under anaerobic conditions; this
trend does not change significantly (as it should) under aerobic conditions.34 The overall findings
were, that cancer cells show a higher glycolytic flux via fermentation, even if oxygen is available.
This has since been termed the “Warburg Effect”.35 The exact benefits of the altered metabolism
for a cancer cell are not fully understood yet,5 but several theories have been proposed, including:
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1) glycolysis and subsequent fermentation is a faster way to produce ATP when resources are low,
which gives tumor cells an evolutionary advantage over the surrounding tissues; 2) the flux
through glycolysis and lactate formation provides more precursors for biomass production and
therefore aids in rapid proliferation;36 3) the reprogrammed metabolism is not a hallmark of cancer
cells, but the source of cancer development itself. No matter which theory is true, the difference in
energy production needs to be addressed if one is to study energetic markers in a cancer cell model
such as the herein used HepG2 cell line.

1.2.4. Nutrient and Energy Sensing
Cellular processes are tightly regulated at all levels, and every process has a certain energy
requirement. Cells manage to maintain their status, through mechanisms that sense the energy
requirement and relate it to nutrient capacity and energy availability. In case of an imbalance,
metabolic pathways can then be stimulated as needed. How effective an organism can sense
fluctuations in environmental nutrient levels determines evolutionary selectivity.37 Two processes
need to be considered for nutrient sensing: a nutrient binding to its receptor, which can propagate
the information of binding, and the ability to detect and sense levels of a compound that directly
reflect nutrient concentration.37 Sensing mechanisms vary for the main three macronutrients, and
vary for intra- and extracellular detection.
When amino acids are scarce, empty tRNAs (the molecules that shuttle amino acids to ribosomes
for peptide synthesis) can be detected intracellularly by the general control nonderepressible 2
protein (GCN2), which can inhibit translation. Lipids, especially fatty acids, bind to G-protein
coupled receptors and set off the release of hormones and other messenger molecules.37 Glucose
sensing has a very complex regulatory framework, due to its importance as the main energy source
in mammalian systems. A multitude of mechanisms exist to assess glucose levels inside and
outside of a cell. One of them is the activity of glucokinase (GCK), which is only active in a state
of intracellular glucose abundance and therefore has the capacity to signal glucose levels. For
extracellular levels, the glucose transporter GLUT2 can import glucose into the cell when the
concentration is high, but exports out of the cell when levels are lower than the intracellular
concentration. AMP-activated protein kinase (AMPK) and mTOR are universally seen as sensors
of cellular energy and nutrient status in eukaryotic cells.38,39 AMPK is sensitive to the ratio of
9

AMP:ATP and influences catabolic and anabolic processes to both, reduce or increase, ATP
production or expenditure.38,40 Phosphorylation of the kinase also modulates its activity to an
increase of more than 100-fold compared to the unphosphorylated form. On top of that, influx of
calcium ions into the cytosol increases AMPK activity and triggers production of ATP.41 Extensive
reviews on the activation and signaling involvement of AMPK have been published by
Hardie.41 – 45 Similarly to AMPK, mTOR has been suggested as a direct sensor of intracellular ATP
as its activity decreases with the levels of the nucleotide.39 Amino acids, fatty acids, metabolites
from nutrient catabolism reactions, and some of their enzymes also alter its activity;39 therefore,
mTOR additionally qualifies as a nutrient sensor. Since both, AMPK and mTOR are highly
involved in nutrient and energy sensing, it is no surprise that their pathways cross and affect each
other’s targets and activities. Their signaling reach is not confined to nutrients and energetics
though, both molecules have critical impact on other functional domains, including cytoskeletal
dynamics, cell growth, and programmed cell death.46 Additionally, signaling around mTOR and
AMPK are essential for the intracellular communication of nutrient levels regarding all three
macronutrient classes.37
A step removed from nutrient awareness is the capability to use these nutrients to produce energy,
or to decide to store them if enough energy is available at a given moment. However, that requires
the systems to be able to sense energy demand and energy availability, especially in terms of ATP,
if a system wants to remain within acceptable metabolic boundaries. A relatively large fraction,
almost 30%, of cellular ATP is devoted to ion pumps, which maintain ion homeostasis under
normal conditions. However, it has been shown that under anoxia, the fraction increases to 74%
and expenditure on other processes decreases, suggesting a hierarchical allocation of energy
resources to the most important activities. ATP itself can act as a regulator for certain pathways,
for example: high concentrations of ATP inhibit phosphofructokinase, the first enzyme in
glycolysis, which reduces the production of ATP. Rising levels of AMP on the other hand, a sign
of an increase of ATP hydrolysis from energy-requiring reactions, activate the same enzyme,
which increases the rate of glycolysis and leads to an increase in ATP production through oxidative
phosphorylation. The same is true for AMPK, which decreases in activity with rising levels of
ATP.47
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1.3. Apoptosis and Autophagy
Eukaryotic organisms are made up of many cells, each with checks and balances to ensure energy
supply, upkeep of function, and proliferation. However, most cells have a limited lifespan which
is tightly regulated by programmed cell death (PCD) pathways. They ideally regulate a cell’s
downfall intracellularly to go by in an orderly fashion without dragging the immediate
environment down the same path. Two primary forms of these PCDs have been identified based
on distinctly different morphological features48: apoptosis (type I) and autophagy (type II).
Anoikis is also categorized as a PCD, however, this form of cell death occurs only when a cell
detaches from the surrounding tissue and undergoes a process very similar to apoptosis due to the
loss of connectivity.49

1.3.1. Apoptosis
Apoptosis is the main form of programmed and genetically encoded cell death, that is especially
important in early stages of mammalian development, where organs and extremities form, that
would otherwise be shapeless.50 Balanced cell proliferation and cell death upholds the status quo
in a biological system. Irregular apoptosis has been connected to a plethora of diseases, the most
prominent being cancer, where the apoptotic programs are turned off or inhibited. Morphological
changes that are characteristic for apoptosis, and easily studied under a microscope, include the
condensation of chromatin and a shrunken nucleus, formation of blebs and apoptotic bodies, and
degraded plasma membranes.49–51
Initiation can either be extrinsic, intrinsic, or granzyme related.48,51–53 If an extracellular molecule
from the TNF family (tumor necrosis factor) binds to their so called “death” receptors on the
plasma membrane, a death-inducing signaling complex (DISC) is formed, and inactive
procaspases (caspase 8 or 10) can dimerize and activate each other by cleavage into caspases.49,54
Intrinsic apoptosis can be triggered in nuclear, reticular, lysosomal, and plasma-membrane
pathways,22 which all seem to converge at the point of Bax/Bak pore formation at the
mitochondrial membrane. Bax and Bak proteins belong to a subfamily of pro-apoptotic molecules
in the family of Bcl-2, which play an integral part in apoptosis.51 Depending on the number of Bcl2 homology domains, members of different subfamilies can have quite the opposite effect on
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mitochondrial membrane integrity. Bcl-2 for example inhibits Bax and Bak interaction by binding
to them.48,49,51,55 In the case of Bax and Bak interaction, insertion into the mitochondrial membrane
leads to pore-like channel formation. With the formation of these pores on the outer mitochondrial
membrane, the permeability increases drastically.53 Thus, species such as cytochrome c are
released into the cytosol.52 Once in the cytosol, cytochrome c activates caspases (caspase 9), which
ultimately lead to cell death.51 Caspases are the best option, if one wants to study a compounds
effect on apoptosis, although it is important to distinguish between the initiating caspases (2, 8, 9,
10) and the effecting caspases (3,6,7), since their activity depends on the timing in the program of
apoptosis.48

1.3.2. Autophagy
The term autophagy very literally describes a biochemical processes, where, in accordance with
the word’s origin, a cell digests itself. When nutrients are less abundant, cellular constituents can
be broken down to yield resources for energy production until nutrients are available again. 56,57
Several factors indicate that the recycling capacity in autophagy is an important part of homeostatic
control and experiments showed a dependence on autophagy for cell survival.58 However,
autophagy can also lead to cell death.53,55,56 During autophagy, cytoplasmic material is enclosed
by an isolation membrane59 into a membranous organelle, the autophagosome, which can fuse with
lysosomes to initiate digestion of the respective material.57 This way, autophagy provides
resources for biosynthesis and cleans up the cytosol.55,57 The autophagosomes are observable by
microscopy as vacuole-like, double-membraned bodies.49 The mitochondria plays a vital role as
the origin of autophagosomal membrane in addition to its role in activating autophagy. Autophagy
occurs constantly at low levels in the cell, however, activity is increased at certain conditions such
as during nutrient deprivation. Eleven autophagy-related (Atg) genes haven been identified in
mammals, prominent ones being Atg8 (LC3) and Atg6 (Beclin1), which initiate the formation of
autophagosomal vesicles.48 If the mitochondrial production and the cellular concentration of ATP
is low, AMPK is activated and can either phosphorylate the serine/threonine-protein kinase UNC51 like kinase 1 (ULK1) directly to upregulate autophagy, or inhibit the mechanistic target of
rapamycin complex 1’s (mTORC1) inhibition on ULKs by inhibitory phosphorylation of
mTORC1s two regulators (tuberous sclerosis complex 2 [TSC2] and regulatory-associated protein
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of mTOR [RAPTOR]), which also leads to a higher rate of autophagy.15As much as scientists want
to classify and bring biochemical processes in order, it is not possible to completely separate
autophagy and apoptosis. They are not two distinct routes of action, but rather intimately linked.55
Efforts to generalize the exact roles and mechanisms have also not been successful, as it appears
that the interplay between them is highly complex and varies in cell types, tissue types, and
individuals.55 Factors that affect autophagy are manifold, greatly relate to nutrient availability
(mTOR, AMPK)46,48,60 and the associated hormone signaling57 and are also linked to apoptosis,48
which has been reviewed by Fan and Zong (2013). To quote their closing remarks:
“autophagy clearly has both pro-survival and pro-death functions, and this is
largely dependent on the cell’s ability to die by apoptosis […] When cellular
damage is too severe, apoptosis kicks in to eliminate irreparable cells to maintain
tissue homeostasis. In cells with defective apoptosis, autophagy may serve as a
backup strategy for cellular demise or as a mechanism to promote other forms of
cell death, such as necrosis.” 55
This interwoven relationship poses a challenge to anyone who wants to study the effects of a
compound on autophagy, since markers should ideally be as exclusive to the investigated
phenomenon as possible. In the field of autophagy research, scientists aim to differentiate between
symptoms that possibly hint to autophagy and actually increased flux through the entire autophagy
pathway.61 An estimate of LC3 (Atg8) is often used to determine induction or inhibition of
autophagy.48 AMPK and mTOR phosphorylation can offer information about the activity and
probably the effects on autophagy.61

1.4. Hormetic Compounds
Plant-based substances (phytochemicals) are commonly investigated for hormetic behavior. These
compounds - often polyphenolic extracts62 that include phytoestrogens, phytosterols, carotenoids,
chlorophyll, isothiocyanates,63 and flavonoids64 - do not hold any nutritional value, since they do
not fall into the category of proteins, carbohydrates, or fats. Phytochemicals often display
antimutagenic and anticarcinogenic properties,65 which sparked the recommendation to ingest at
least five servings of vegetables and fruit (sources of phytochemicals) in the hope that these aid in

13

the prevention, retardation, treatment, or cure of certain diseases, including cancer.1,6,66
Interestingly, due to their biphasic behavior, hormetic substances can, at lower doses, protect cells
from DNA damage and the subsequent development of cancer, and at higher doses, be used as
therapeutic supplements against cancer due to their cytotoxicity.3 Bits and pieces of the exact
modes of action for phytochemicals are known, but the whole picture remains to be clarified,5 and
the question persists if they share a common mode of action in the concept of hormesis, or if each
phytochemical triggers its own profile of distinct beneficial processes inside the cell.66 Some
common affected targets have been summarized by Murugaiyah and Mattson (2015), which
include AMPK and mTOR.1

Figure 4| Chemical structures of curcumin, resveratrol, quercetin, and epigallocatechin-3-gallate.

1.4.1. Quercetin
Quercetin is a flavonoid derived from nuts, seeds, olive oil, vegetables, herbs, buckwheat, and teas,
and is highly abundant in the human diet.3,67–69 The main properties ascribed to quercetin are
associated with ROS and their potential damage to tissue. As an electron donor to ROS67 and a
chelator for certain metal ions, quercetin achieves anti-oxidant results, and therefore has been
shown to decrease the incidence of DNA damage and the chances of cancer development. 3
Additionally, quercetin can induce expression of the DNA repair protein 8-oxyguanine DNA
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glycosylate (hOGG1)67,70 and activates the antioxidant glutathione.67,69 Induction of
metallothioneins (MT) by quercetin has been reported to protect against heavy metal toxicity in a
liver carcinoma model.71 These properties are observed at doses below 40 µM,3 although Kim et
al. (2009) observe antioxidant effects up to 100 µM 30 minutes post-exposure. Tan et al. (2009)
found that simultaneously decreased levels of the anti-apoptotic proteins survivin and Bcl-2 as
well as increased levels of p53 and increased activity of caspase-3/-9 cause cytotoxicity in HepG2
cells, but their data did not support hormetic behavior.72 There is no clear agreement on quercetin’s
hormetic properties, which is why the compound should be investigated more thoroughly.

1.4.2. Epigallocatechin Gallate
The green tea, black tea, and red wine component epigallocatechin gallate showed a beneficial
antioxidative character in several studies,73 and has additionally been found to have anticarcinogenic, anti-angiogenic, as well as anti-proteolytic features,74 especially in cases of ethanol
and hypoxia induced damage, where epigallocatechin gallate ameliorated the effects.73,74 In HepG2
cells, induction of autophagy has been assigned to an exposure of 40 µM of catechin,75 while
Shen et al. (2014) reported a decrease in autophagy induction of approximately 25% after a 24and 48-hour exposure of 87 µM and by 45% after 78 hours.76 Additionally, 174.5 µM and 262 µM
inhibited metabolic activity in the same cell line by 40 – 45% after 24 hours, 65% after 48 hours,
and 70% after 72 hours, respectively. Hormesis tends to be observed at lower concentrations than
the ones listed here, so an expansion of the dosing range into smaller concentrations might reveal
hormetic behavior. For a review of epigallocatechin gallate’s origin, bioavailability, see Roberto et
al. (2016).77

1.4.3. Curcumin
Derived from turmeric, curcumin is a yellow to orange colored powder that has been extensively
studied in the last years, especially with respect to the prevention and treatment of cancer.78
Cellular effects found in vitro and in vivo in varying cell lines include the induction of
mitochondria mediated apoptosis,78–80 autophagy,80,81 disruption of mitochondrial membrane
potential,79 increase in calcium ion concentration,79 antioxidant characteristics through binding of
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Nrf282 and prooxidant characteristics at higher doses. In HepG2 cells, Wang et al. (2011) observed
a decline in cell viability response by 20% starting at 5 µM, almost linearly decreasing until onefifth of the control values at 20 µM.79 In a different paper, Qian et al. (2011) found a 20% increase
in cell viability after a 12-hour exposure to 5 µM, while all other exposures of 24 and 36 hours to
20 and 50 µM either did not affect the cell viability compared to controls, or decreased cell
viability. Therefore, curcumin might show hormetic behavior.

1.4.4. Resveratrol
Resveratrol is a polyphenol found in peanuts and grapes, predominantly, that has been thoroughly
studied for antiproliferative, chemo-preventive, cardio-protective, immune system improving,
antiaging, gut health regulating, and antioxidant effects.83–87 Marcsek et al. (2007) found slight,
but not significant, increase in cell proliferation after exposing HepG2 cells to 0.1 to 100 µM for
24 hours. After 48 hours, cell viability was unaffected by concentrations up to 12.5 µM but
declined from there to about 50% (100 µM), and 72-hour exposures gave similar results.83
Plauth et al. (2016) on the other hand found increased cell viability up to 100 µM in the same cell
line, although exposure time was only 16 hours.84 An increase in signal from MTT assays by 20%
for resveratrol concentrations between 30 and 50 µM after 24 hours was reported, but the effect
did not last for an exposure of 48 hours.88 Such proliferative effects have been observed in a variety
of human cancer cell lines and preventive effects for other diseases, such as Alzheimer’s or gastric
ulcers, have also been described.89 Additionally, co-exposure of resveratrol with, for example,
matrine or formaldehyde, decreased the detrimental effects of the cytotoxic substances.83,90
Between the three previously cited papers, it is clear that resveratrol causes a hormetic adaption,
however, exact concentrations vary mainly because the exposure times are not matched. A more
detailed study into these two aspects should be able to resolve uncertainty.
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2. Experimental Design, Methods, and Materials
2.1. Experimental Design
This work aims to clarify the concentration and exposure duration dependence in hormetic
behavior for several compounds. For this thesis, four compounds were chosen, based on literature
review, and human hepatocyte carcinoma cells were exposed to varying concentrations. The first
set of experiments was meant to screen these four compounds for the best concentration range to
observe potentially biphasic behavior. Depending on the results, compounds were then selected
for additional studies involving a series of different exposure times to address the duration
dependence. Concentration ranges were kept constant throughout this part to ensure complete
comparability of data.

2.1.1. In vitro Model
For the herein described experiments, a human hepatocyte carcinoma cell line (HepG2) was
chosen as the in vitro model. The mammalian liver hosts major phase I and phase II metabolism
of xenobiotics, and offers detoxification capabilities, but can also yield metabolites with increased
harm for the system. Therefore, metabolic experiments from this cell line can deliver important
information about the pharmacokinetic nature of phytochemicals. In addition, the cell line provides
insight into liver carcinoma-specific metabolism and how the investigated compounds can affect
cancer cell survival.5 Although single-cell experiments give a more exact picture on metabolic
changes,12 measurements from a cell population can at least suggest trends and point into the right
direction for further studies.

2.1.2. Cell-based Assays
Four substances were chosen due to their previously reported hormetic behavior or their potential
for hormetic behavior: Curcumin, epigallocatechin gallate, resveratrol, and quercetin. The initial
experiments aim to characterize appropriate concentration ranges, optimize assay conditions, and
rule out compounds that give inconsistent results. Subsequent experiments monitor the metabolic
activity and plasma membrane degradation across the determined concentration range. Exposure
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duration dependence was examined through measurements six, twelve, 24, 48, and 72 hours after
a one-time dose of the compound.
Concentration ranges investigated were: 0.01 - 500 µM curcumin and epigallocatechin gallate,
0.01 - 2000 µM resveratrol and quercetin. Quercetin’s effects greatly depend on the route of
metabolism in the body, which is vastly branched.3 Isorhammetin and tamarixetin are two wellstudied metabolites, but for the purpose of this study, pure quercetin was used, since it appears to
have the largest anti-oxidant effect.3 Based on Lüer et al.’s (2014) demonstration that synthetic
and natural curcumin have the same cellular effects, synthetic curcumin was employed in
experiments.91 While resveratrol exists in three forms in red wine (trans-, cis-, and dihydroresveratrol), trans-resveratrol makes up the predominant constituent, which is why that species
was chosen for investigation.92 Epigallocatechin 3-gallate was employed for similar reasons
(abundance in tea) and will further be referred to as epigallocatechin gallate.
Effects on cell viability after an exposure of 24 hours are assessed with the widely used MTT
assay. Active cellular metabolism in live cells is commonly measured making use of MTT
tetrazolium (3,[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide), which is converted
to formazan by reducing molecules inside the cell.93 The exact mechanism is not known yet, but it
is assumed that MTT enters the cell through endocytosis and is reduced by several substrates,
including succinate, malate, glutamate, NADH, and NADPH.93 Liu et al. (1997) showed, however,
that the reduction of MTT does not only rely on active mitochondria, as has been widely stated.
Therefore, this assay merely measures metabolic production of reducing substrates. The amount
of formazan increases linearly with cell number, presuming their metabolism is the same. Varying
metabolic rates, for example in cells at different stages, can influence linearity and skew results.94
MTT is usually dissolved in buffer, such as PBS, at a concentration of approximately 5 mg/mL95
and diluted ten-fold in the assay well. Formazan accumulates as a purple crystalline precipitate
over several hours; therefore, plates need to be incubated at 37 °C to increase sensitivity and signal
stability. The blue-purple crystals are then solubilized, with solutions ranging from isopropanol
and dimethylsulfoxide to preparations of SDS in DMSO,94 and the relative concentration of
formazan can be measured through absorbance at 570 nm. Assay kits supplying an MTT solution
and detergent are commercially available.
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Exposure effects leading to cell death through plasma membrane integrity are studied with
ethidium-D1 homodimer When cells undergo cell death after a xenobiotic insult, the cell
membrane is found to be compromised, which equals an increase in premeability.96 This can be
used to label dead cells with a - in principle - cell impermeable compound, such as ethidium-D1
homodimer, which binds to nucleic acid once it entered into the cytosol of a damaged cell. 97 The
free nucleic acids is another sign of a cell moving towards cell death, especially during coordinated
cell death (apoptosis), since the nucleus undergoes sequestration and the DNA is broken down. 49
The homodimer chelates the double stranded nucleic acids98 and exhibits a red fluorescence99 that
can be measured at excitation/ emission wavelength 530/645 nm.

2.2. Methods and Materials
2.2.1. Materials
HepG2 cells were acquired from ATCC (ATCC® – HB-8065™). Cell culture media was prepared
from Dulbecco’s Modified Eagle’s Medium (Sigma-Aldrich) in deionized water from a EMD
Milipore DirectQ Water System. D-(+)-glucose, sodium pyruvate, L-glutamate monosodium
hydrate, and sodium bicarbonate were purchased from Sigma-Aldrich. 100X solutions of
streptomycin and penicillin were acquired from Corning, HyClone fetal bovine serum defined
from Thermo Scientific and HEPES from Fisher BioReagents. 0.05% trypsin with 0.53 mM EDTA
(1X), Costar polystyrene tissue culture treated clear flat bottom 96 well plates (low evaporation
lid), Costar polystyrene tissue culture treated black with clear flat bottom 96 well plates, and T75
cell culture flasks with vented caps were procured through Corning. HPLC grade methanol was
purchased from EMP, DMSO from Fisher BioReagents, 0.4% trypan Blue from MP, ethidium
homodimer-1 from Invitrogen Molecular Probes, and the TACS® MTT Cell Proliferation Assay
Kit from Trevigen. Quercetin, (-)-epigallocatechin gallate, and trans-resveratrol, were obtained
from Cayman Chemical Company, while curcumin was purchased from Acros Organics.
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2.2.2. Cell Culture
HepG2 (human hepatocellular carcinoma-derived) cells were cultured in cell line specific medium
(DMEM, 2 g/L D-glucose, 10% fetal bovine serum, 100 mg/mL streptomycin, 100 U/mL
penicillin, 1 mM sodium pyruvate, 2 mM L-Glutamate, 5 mM HEPES, and 24 mM sodium
bicarbonate) and maintained at 37 °C in humidified, 5% CO2 atmosphere. Cells were passaged at
70% - 90% confluence, using trypsin EDTA as lifting agent. Cell density was determined after
trypan blue staining on a Reichert Bright-Line® Improved Neubauer hemocytometer in 10 μL of a
1:1 dilution of cell solution in staining reagent (20 µL each). For all assays, approximately 40 000
cells/100 μL were seeded into 96 well plates (clear for absorbance assays, black with clear bottoms
for fluorescence) in indicator-free medium and allowed to reattach for 24 hours before dosing.

2.2.3. Dosing
Stock solutions of all compounds were prepared in DMSO in accordance with the substances’
solubility: 10 mM and 50 mM curcumin, 50 mM epigallocatechin gallate, 100 mM resveratrol,
and 100 mM quercetin.
100X dosing solutions were freshly mixed by diluting appropriate amounts of stock solution in
DMSO, which were subsequently diluted 100-fold in cell culture medium to yield the final dosing
concentrations. Curcumin: 0.01, 0.1, 0.5, 1, 5, 10, and 50 µM. 100 and 500 µM dosing solutions
were created by directly diluting the 10 mM or 50 mM stock solution 1:100 in cell culture medium.
Epigallocatechin gallate: 0.01, 0.1, 1, 5, 10, 25, 50, 70, 100, 150, 200, 250, 300, and 400 µM.
500 µM dosing solutions were created by directly diluting the 50 mM stock solution 1:100 in cell
culture medium. Quercetin and resveratrol: 0.01, 0.1, 1, 5, 10, 25, 50, 70, 100, 200, 400, 500, 600,
and 800 µM. 1000 µM dosing solutions were created by directly diluting the 100 mM stock
solution 1:100 in cell culture medium, 2000 µM dosing solutions were created by directly diluting
the 100 mM stock solution 1:50 in cell culture medium. All dosing solutions had a final DMSO
concentration of 1% or 2%. Dosing solutions used in different assays may not include all listed
concentrations and can vary between plates.
24 hours after seeding, spent cell culture medium was aspirated and discarded, and cells were
supplied with 100 µL fresh culture medium in the form of the dosing solutions. 96 well plates were

20

either incubated for the respective exposure time at 37 °C in humidified, 5% CO2 atmosphere or,
for real-time measurements, covered with plate tape and kept at 37 °C in the plate reader.

2.2.4. Assays
All plates were evaluated using a Tecan InfiniteM100 plate reader (Tecan US, Raleigh, NC) and
Tecan i-control 1.10 software.

2.2.4.1.

MTT Assay

Cell viability assays were performed using the TACS® MTT Cell Proliferation Assay Kit
(Trevigen) per manufacturer’s protocol. Briefly, at the end of the respective exposure time,
10 µL/well MTT reagent (3,[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) were
added. After six hours of incubation at 37 °C, 100 μL detergent were dispensed in each well, the
plates covered in aluminum foil and stored in a dark cupboard for twelve hours. Absorbance was
then read from the bottom at 570 nm. Controls for this assay included untreated 1% and 2% DMSO
vehicle controls (where necessary), as well as blank controls without cells at each concentration
for background absorbance, since some substances showed an increased absorbance with increased
concentration. Control and experimental wells were treated identically throughout the assay.
Average absorbance values were corrected for background absorbance from the blank controls and
normalized to untreated vehicle controls wells.

2.2.4.2.

Plasma Membrane Degradation Assay

Plasma membrane degradation assays were performed using ethidium-D1 homodimer. 1 mg was
dissolved in 20% aqueous DMSO to a concentration of 2 mM. After the respective incubation
period, 100 μL of 4 μM ethidium D-1 homodimer in culture medium were added to each well for
endpoint experiments and kept at 37 °C in humidified, 5% CO2 atmosphere for 20 minutes.
Fluorescence was measured from the bottom with excitation at 530 nm and emission at 645 nm.
Controls for this assay included untreated 1% DMSO vehicle controls, blank controls without cells
at each concentration, and control wells of 100% dead cells (removal of reaction mixture and
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addition of 100 μL 70% methanol in medium 30 minutes prior to the end of the respective
incubation period) for maximum signal. Control and experimental wells were treated identically
throughout the assays. Average fluorescence values were corrected for background fluorescence
through blank control values and normalized to maximum signal responses (unless otherwise
specified).

2.2.5. Data Evaluation and Statistical Analysis
Data from cell-based assays were exported and analyzed with Prism 5.03 (GraphPad), values are
reported as the mean ± standard error of the mean. For cell viability assays, values were first
corrected by subtracting the corresponding blanks and then normalized to the vehicle control (no
treatment, assumed 100% live). For plasma membrane degradation assays, values were first
corrected by subtracting the corresponding blanks and then normalized to the dead control (70%
methanol 30 minutes prior to the end of the exposure time, assumed 100% dead). Statistical
significance was determined using one-way ANOVA with Bartlett’s test for equal variances and
Bonferroni’s Multiple Comparison Test. The following notation is used to report p-values (unless
otherwise specified): * p≤ 0.05, ** p≤ 0.01, *** p≤ 0.001 compared to vehicle control; # p≤ 0.05,
##

p≤ 0.01, ### p≤ 0.001 compared to the previous concentration, ° p≤ 0.05, °° p≤ 0.01, °°° p≤ 0.001

compare to the previous exposure time.
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3. Results and Conclusion
3.1. Substance Screening
Human hepatocyte carcinoma cells (HepG2) were exposed to varying concentrations of
epigallocatechin gallate, resveratrol, quercetin and curcumin for 24 hours. Effects on metabolic
activity and plasma membrane integrity were assessed using MTT (3,[4,5-dimethylthiazol-2-yl]2,5-diphenyl-tetrazolium bromide) and ethidium-D1 homodimer, respectively. Results are
summarized in Figure 5 and Table 1. Substances were screened for hormetic behavior, e.g. an
increase in metabolic activity above controls level and a simultaneous decrease in plasma
membrane degradation at lower concentrations; a decrease of metabolic activity associated with
an increase in plasma membrane degradation at higher concentrations.

3.1.1. Epigallocatechin Gallate, Quercetin, and Curcumin
Effects of epigallocatechin gallate treatment on metabolic activity at concentrations up to 10 µM
were unchanged from basal control levels. From 25 to 500 µM, the metabolic activity increased in
the mean by 28 to 86%. However, variability in the four independent experiments was high and
the variance in means did not show a significant change at higher concentrations. Additionally, no
decrease in metabolic activity was observed. Plasma membrane degradation results showed a
decrease compared to vehicle controls at 25 and 50 µM. Data points from higher concentrations
consistently gave invalid results and are not included here. In theory, a decrease in plasma
membrane degradation in association with an increase in metabolic activity matches hormetic
behavior. Nevertheless, variability was considerably too high, especially in MTT results, to
recommend epigallocatechin gallate for further duration dependence experiments. Zapf et al.
(2015) concluded that an exposure of 4.4 µM over twelve, 24, and 48 hours did not decrease cell
viability in the same cell line, which the herein presented results support.100 However, Shen et al.
(2014) reported decreased metabolic activity from 87, 174.5, and 262 µM (25%, 45%, 45%,
respectively) after 24 hours of exposure, 76 which is partially matched by other studies,101 but was
not reproduced in the presented experiments. In fact, our results rather suggest an increase in
metabolic activity for concentrations above 100 µM. The typical hormetic dose response behavior
was not observed for the investigated cell line. Naponelli et al. (2015) reported that
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epigallocatechin gallate induces endoplasmatic reticulum stress in prostate cancer cells, but the
cells were able to overcome this stress at least between the first six to twelve hours. After that,
76 µM induced anoikis, and 316 µM induced cell death.58 In its nature as a catechin,
epigallocatechin gallate is presumed to owe its beneficial character to the activation of Nrf2, which
increases activity of phase II enzymes.6 Calabrese et al. (2010) state that various pathways can be
influenced by this molecule, including protein kinase C, Bcl-2 family members, and antioxidant
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Figure 5| Metabolic activity and plasma membrane degradation after 24-hour exposure to epigallocatechin gallate, resveratrol,
quercetin, and curcumin.
HepG2 cells were exposed to varying concentrations of epigallocatechin gallate (top left), resveratrol (top right), quercetin (bottom
left), or curcumin (bottom right) for 24 hours. Effects on metabolic activity were assessed using MTT, effects on plasma membrane
integrity were assessed using ethidium homodimer-1. Data shown represent the mean and the standard error of the mean from four
independent experiments. Experimental values were measured in duplicate, triplicate, quadruplicate, or sextuplicate.
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enzymes.102 Ye et al. (2012) found activated SIRT1 signaling (an energy sensor for NAD+) when
PC12 cells - a rat adrenal gland cell line - were exposed to a cytotoxic compound (MPP+)
alongside 10 µM epigallocatechin gallate, which increased cell viability markedly compared to
treatment with the cytotoxic compound alone.103 The green tea extract undoubtedly exerts positive
effects, but is most likely not a hormetin.
Similar to epigallocatechin gallate, exposure to quercetin did not trigger a change in cellular
behavior at low doses up to 10 µM. From 50 µM to 2000 µM, trends in metabolic activity and
plasma membrane degradation complemented each other, however, none of the increases or
decreases are statistically significant and the standard error of the mean at higher concentrations
was considerably high with regards to metabolic activity. Additionally, quercetin precipitated out
of the culture media for concentrations above 500 µM soon after dosing, therefore the true
concentration in media is unknown. Considering that, no evidence has been found that quercetin
exerts hormetic behavior below 800 µM and quercetin was not included in additional experiments.
While there were observable trends associated with metabolic activity and plasma membrane
integrity, the results mostly do not agree with literature values. Tanigawa et al. (2008) found a
decrease in MTT response after 24 hours from 20 µM,104 while Tan et al. (2009) observed a
considerable decrease in MTT response after 24 hours starting at 12.5 µM and an even bigger
effect after 48 and 72 hours.72 However, Weng et al. (2011), mention no decrease in MTT response
up to 50 µM,71 which these experiments support. The problem of quercetin stability in culture
media has been addressed previously,68 finding that solutions of quercetin above 80 µM start to
precipitate out at a pH of 7.4. Therefore, literature values should be taken with a grain of salt if
they claim results for anything higher than 80 µM, as is the case for the results presented here and
in Pietsch et al.’s 2011 publication.66
No statistically significant change in metabolic activity was observed from curcumin exposure,
although the data displays a slight upward trend at 50 µM before returning to control level at
100 µM and subsequently decreasing to less than 50% at 500 µM. Measurements involving plasma
membrane degradation were challenging, since curcumin posed an experimental challenge due to
its absorption at the experimental wavelength which has been previously discussed.105,106 Several
control groups (blanks at each concentration including dosing vehicle, blanks of cells with dosing
reagent at each concentration without assay reagent, and dead controls for maximum signal) and

25

data manipulations were employed assuming to account for the analyte signal, but data evaluation
did not yield usable values. Therefore, curcumin was no longer pursued. Literature so far has
reported hormesis-like effects on HepG2 cells at low doses of 5 µM after twelve hours of exposure,
while the same paper does not see hormetic behavior after an exposure of 24 hours, which our
results support.81 Besides its multitude of positive effects on the human organism, it appears that
curcumin does not act like a hormetin, at least not in the investigated liver cancer model.
Adenocarcinoma cells (MCF-6) on the other hand seem to increase proliferation up to about 75 µM
after 24 hours, with no significant decrease in proliferation up to 100 µM.68 The flavonoid structure
allows for a potential inhibition of tyrosine nitration, which would relief excessive nitrosative
stress.64 Concentrations higher than 40 µM exert cytotoxic effects based on quercetin acting as a
ROS itself.3 Data from breast cancer cells (MDA-MB-231) has been presented,107 however, the
authors did not see a significant decrease in cell viability until cells were exposed to 100 µM for
24 hours.107 Vargas and Burd’s findings (2010) suggest a mitochondrial and a death-domain
apoptotic pathway.3 Pietsch et al. (2011) found that doses of 100 and 200 µM induced proliferation
in C. elegans, but reduced the same metric at a dose of 250 µM.66

3.1.2. Resveratrol
Exposure to resveratrol exhibited a clear trend in metabolic activity and plasma membrane
degradation. Doses below 10 µM did not change the cellular response compared to basal level in
both assays. An increase in metabolic activity of 38% and 57% stood out for 50 µM and 100 µM,
respectively, although not statistically significant, while the level of plasma membrane degradation
steadily increased from a control level of about 15% (compared to 100% dead) to 25% for 100 µM
and even almost 45% for the highest doses of 250, 400, and 500 µM. The change in plasma
membrane integrity was statistically significant for 100, 250, 400, and 500 µM. 500 µM also
significantly decreased metabolic activity to less than 15% of basal level. In the presented
preliminary experiments, resveratrol did not show statistically significant hormetic behavior,
however, the standard error of the mean was smaller and data more consistent than other
compounds in question. Therefore, HepG2 cells were exposed to varying concentrations of
resveratrol for six, twelve, 24, 48, and 72 hours.
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Table 1| Summary of statistically significant changes in metabolic activity and plasma membrane integrity by
compound concentration compared to untreated vehicle controls and the previous concentration.
Compared to Untreated Vehicle Control
Concentration [µM]

* p≤0.05
** p≤0.01
*** p≤0.001

Compared to Previous Concentration
#

Concentration [µM]

p≤0.05
p≤0.01
### p≤0.001
##

Epigallocatechin Gallate
Metabolic Activity
Plasma Membrane Integrity

No statistically significant changes
50 & 75

**

100 - 500

***

No statistically significant changes
No statistically significant changes
Resveratrol

Metabolic Activity
Plasma Membrane Integrity

500

***

No statistically significant changes

100

**

100

#

200 - 500

***

400

###

Quercetin
Metabolic Activity

No statistically significant changes

No statistically significant changes

Plasma Membrane Integrity

No statistically significant changes

No statistically significant changes
Curcumin

Metabolic Activity

500

***

500

###

3.2. Resveratrol: Concentration and Duration Dependence
Preliminary 24-hour exposure experiments in HepG2 cells showed promising results for hormetic
behavior associated with resveratrol. To test concentration and exposure duration dependence, the
same cell line was exposed to varying concentrations (0.1 – 500 µM) for six, twelve, 24, 48, and
72 hours and the aspects of metabolic activity and plasma membrane integrity were investigated.
Results are summarized in Figures 6, 7, and 8, and Tables 2 and 3.
Figure 6 presents data from metabolic activity and plasma membrane degradation measurements
for each time point. The panels clearly show an increase in metabolic activity for certain
concentrations, while plasma membrane degradation mainly stayed at basal levels until
concentration and exposure times increased.
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In detail, cellular responses associated with metabolic activity were approximately the same after
six and twelve hours, with an increase in metabolic activity caused by 50 and 100 µM by 30% and
85 – 89% of the basal control level respectively. Values obtained from 250 µM show a 10% higher
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Figure 6| Metabolic activity and plasma membrane
degradation after exposure of HepG2 cells to resveratrol for
six, twelve, 24, 48, and 72 hours.
HepG2 cells were exposed to 0.1, 1, 10, 50, 100, 250, and 500 µM
for six (top left), twelve (top right), 24 (middle left), 48 (middle
right), and 72 hours (bottom). Effects on metabolic activity were
assessed using MTT, effects on plasma membrane degradation
were assessed using ethidium homodimer-1. Data shown
represent the mean and the standard error of the mean from four
to six independent experiments. Experimental values were
measured in quadruplicate for blanks, triplicate for controls, and
sextuplicate for experimental wells.

metabolic activity, but the variances in the mean were not statistically significant. 500 µM
resveratrol considerably reduced cellular activity to approximately 75% of the untreated controls.
Metabolic activity noticeably (and statistically significantly) changed between twelve and 24
hours. After 24, 48, and 72 hours, 250 µM doses inhibited metabolic activity to less than 50% on
average, and 500 µM decreased to less than 15%. 50 µM did not increase the cellular response,
but 100 µM did for all three later exposure times. The spike of 35% after 24 hours, 26% after 48
hours, and 22% after 72 hours was statistically significant. The disconnect between the early time
points of six and twelve hours to the later time points of 24 to 72 hours is especially well presented
in Figure 7 (left panel). The right panel in the same figure shows that from 50 to 500 µM, the
cellular behavior follows the same trend, where the dose increases metabolic activity from 6 to 12
hours, and then decreases relative to the previous level from 24 to 72 hours. This change is
statistically significant between exposure points from 12 to 24 hours at compound concentrations
of 50, 100, 250, and 500 µM. It clearly shows that 100 µM has the largest initial influence on the
cell, with the highest increase in activity. 50 µM has a comparable effect, but in a smaller
magnitude. Interestingly, another trend can be observed at lower concentrations between 0.1 and
10 µM: with an increase in exposure time, the metabolic activity increased, which seems to be
distinctly different than after six and twelve hours, but is not statistically different.
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Figure 7| Metabolic activity of HepG2 cells exposed to resveratrol for 6 to 72 hours.
Comparison of the different concentrations (left) and exposure times (right). A clear change in metabolic activity was observed
between twelve and 24 hours, especially in response to 50, 100, 250, and 500 µM. A slight increase over time is noticeable for
lower concentrations from 0.1 to 10 µM. Data shown represent the mean and the standard error of the mean from four to six
independent experiments. Experimental values were measured in quadruplicate for blanks, triplicate for controls, and sextuplicate
for experimental wells.
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Figure 8| Plasma membrane degradation of HepG2 cells exposed to resveratrol for 6 to 72 hours.
Comparison of the different exposure times (right) and concentrations (left). Plasma membrane integrity was noticeably
compromised after 48 hours of exposure to 250 and 500 µM. An initial decrease in plasma membrane degradation was
observed for all concentrations. Data shown represent the mean and the standard error of the mean from four to six
independent experiments. Experimental values were measured in quadruplicate for blanks, triplicate for controls, and
sextuplicate for experimental wells.

The plasma membrane degradation data points a similar picture. No significant changes in plasma
membrane integrity were observed for exposures duration up to twelve hours. After 24 hours,
concentrations of 250 and 500 µM slightly increased plasma membrane degradation compared to
the vehicle control, after 48 hours, 100, 250, and 500 µM displayed an increase to 14, 28, and 44%
(of 100% dead). After 72 hours, 250 and 500 µM raised the degree of plasma membrane
degradation to 50 and 83% in the mean (of 100% dead), respectively. Figure 8 (left) shows that
from time point to time point, cellular behavior changed significantly from 24 to 48 hours
concerning doses of 100, 250, and 500 µM, but also between 48 and 72 hours for 250 and 500 µM
concentrations. When the data was plotted against time, all concentrations initially decreased
plasma membrane degradation from six to twelve hours, although not statistically significant, it is
a clear trend. Worth noticing is, again, the difference in behavior from low doses, which did not
change plasma membrane integrity over time, and high doses, which evidently affected membrane
degradation starting at 24 hours.
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Table 2| Summary of statistically significant changes in metabolic activity and plasma membrane integrity
between exposure times by resveratrol concentration.
Compared to Previous Exposure Time
Exposure Time
Metabolic Activity

Concentration [µM]
50
100 - 500
100
250 & 500
250 & 500

12 vs. 24 hours
24 vs. 48

Plasma Membrane Integrity

48 vs. 72

° p≤0.05
°° p≤0.01
°°° p≤0.001
°°
°°°
°
°°°
°°°

Table 3| Summary of statistically significant changes in metabolic activity and plasma membrane integrity after
varying exposure times by resveratrol concentration compared to untreated vehicle controls or the previous
concentration.
Compared to Untreated Vehicle Control
Concentration [µM]

* p≤0.05
** p≤0.01
*** p≤0.001

Compared to Previous Concentration
#

Concentration [µM]

p≤0.05
p≤0.01
### p≤0.001
##

6-hour Exposure
Metabolic Activity
Plasma Membrane Integrity

50 & 100

***

No statistically significant changes

50
100 - 500

##
###

No statistically significant changes

12-hour Exposure
Metabolic Activity
Plasma Membrane Integrity

50 & 100

***

No statistically significant changes

50 – 500

###

No statistically significant changes

24-hour Exposure
Metabolic Activity
Plasma Membrane Integrity

100
250 & 500
250
500

*
***
***
**

250
500
250
500

###
##
###
#

48-hour Exposure
Metabolic Activity
Plasma Membrane Integrity

100

**

100

##

250 & 500

***

250 & 500

###

100
250 & 500

*
***

250
500

##
###

72-hour Exposure
Metabolic Activity
Plasma Membrane Integrity

100

*

100

#

250 & 500

***

250 & 500

###

250 & 500

***

250
500

##
#
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With the assumption that the metabolic rate across the sampled cell population is - on
average - the same, an increase in metabolic rate from the MTT assay can be seen as an increase
in cell proliferation (more metabolic activity equals more metabolically active cells). Four striking
observations were made: 1) Low concentrations (0.1 to 10 µM) display no statistically significant
change in metabolic activity or plasma membrane integrity, but with increasing exposure time, a
trend of a subtle increase in cell proliferation (Figure 6, right panel) and a subtle decrease in plasma
membrane degradation (Figure 7, right panel) can be associated with these doses. 2) Higher
concentrations (50 to 500 µM) evoke the same trend in HepG2 cells, opposite to the one observed
for lower concentrations: Cell proliferation decreases as the exposure time increases; plasma
membrane degradation increases as the exposure time increases. 3) Over the time course of 72
hours, the cellular behavior changes for the doses of 50, 100, and 250 µM: During the first twelve
hours, the three concentrations increase metabolic activity; after 24 hours, only 100 µM still raises
the assay response above control level. The two duration groups (six and twelve hours, 24 to 72
hours) share almost the same response to resveratrol. Therefore, at a time point between twelve
and 24 hours, something changes in the cellular metabolism. Plauth et al. (2016) investigated
resveratrol’s effect on antioxidants and metabolite couples’ concentrations, and found a
significantly changed intracellular redox environment 16 hours after dosing. 4) When comparing
metabolic activity and plasma membrane degradation at 100 µM, one can see that both increase,
especially with an increase in exposure time (Figure 6). This suggests that cellular metabolism
increases but the cellular membrane is also increasingly compromised, which might either be
rooted in heightened flux in pathways that combat cell death via plasma membrane degradation or
the opposite, heightened flux in pathways that eventually cause the permeabilization.
The basis of the hormetic concept was a discovery by Prof. Hugo Schulz, that bacterial metabolism
was stimulated. However, it might be important to distinguish between increased metabolism that
is beneficial for the cell and increased metabolism that has detrimental effects. With that in mind,
the increase in metabolic activity at higher concentrations does not necessarily mean an increase
in proliferation. If a cell shifts its metabolism and increases flux through pathways that yield
reducing agents then the response to the MTT reagent is heightened. Therefore, the previously
made assumption (more metabolic activity equals more metabolically active cells) would not apply
here and it would be important to investigate which pathways are induced clarify the situation.
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In general, it is known that resveratrol influences and mimics energy restriction through the
interaction with AMPK and SIRT1,88,108,109 and triggers apoptosis through increased p53
expression, caspase 9 and 3 activation, and a shift in Bax/Bcl-2 ratio.88,90 Long-term exposure
studies on mesenchymal stem cell revealed hormetic behavior in the concentrations range from
0.1 to 5 µM during a 30 day period,110 hepatic stellate cells (GRX) did not experience hormesis
after 24 or 120 hours of exposure, just a decrease in cell viability.111 These two examples show the
importance of a completely resolved concentration and duration profile, especially in differing cell
lines.

3.3. Conclusion
Four compounds were investigated for their hormetic behavior in a human hepatocellular cancer
model in terms of metabolic activity and plasma membrane degradation. Epigallocatechin gallate,
quercetin, and curcumin did not show significant hormetic behavior. Resveratrol exerted hormetic
behavior in a time- and dose-dependent manner associated with concentrations of 50, 100 and
250 µM. Low concentrations up to 10 µM showed a trend toward hormesis, albeit not statistically
significant, which was opposite to the trend observed for higher concentrations. Cellular behavior
associated with 100 µM resveratrol deserves a short note, since both, metabolic activity and plasma
membrane degradation showed higher values. This points to increased signaling and reductive
species production associated with pathways that eventually affect plasma membrane integrity.
The herein presented data therefore adds to the literature that supports resveratrol as a hormetic
compound.
Vargas and Burd (2010) bring up an important point in their review: Most studies on hormetic
compounds only involve in vitro and rarely in vivo work. 3 From in vitro and in vivo work, it is
almost too farfetched to give recommendations on supplemental ingestions of specific
phytochemicals. Conclusion like these would require a lot more extensive basic research into the
biochemical processes associated with each phytochemical. One needs to account for clearing rates
in a cell, residence times in a cell, metabolism until the compound reaches the target cell, the
ultimate concentration inside the cell, and the individual variability in metabolism rate. Especially
since, if a compound exhibits hormetic features, a low concentration (aka not enough of the
phytochemical ingested) can have the exact opposite outcome than the desired one. This concern
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has already been voiced by Calabrese et al. (2010): with respect to anticarcinogenic characteristics,
a low dose increases instead of decreases the risk of tumor cell growth.89 Hormesis is undoubtedly
a phenomenon that requires more in-depth attention and better method design. The two main
questions, if there is a universal underlying pathway for hormesis, or if a compound triggers its
own profile of distinct beneficial processes inside the cell, have not been answered yet, despite the
growing literature on hormesis. The example of resveratrol, however, shows how important it is
to incorporate a wide range of concentrations and include several more time points (exceeding the
norm of 24 hours).
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4. Future Directions

Resveratrol causes a noticeable switch in cellular behavior in HepG2 cells between 12 and 24
hours of exposure, significantly different especially at concentrations from 50 to 250 µM. These
findings open the floor to studies that further explore the metabolic basis of hormesis associated
with resveratrol. Future experiments should include the assignment of exact post exposure
timepoints with real-time assays, to pinpoint when signaling in the cell changes, and consecutive
analysis of metabolic markers at these times.

4.1. Assigning Crucial Energetic Signaling Timepoints
Since virtually every metabolic pathway requires energy, changes in cellular energy production,
and changes in cellular ATP, can be a clue for an adaptive change. Luciferase assays have been
used to determine the concentration of ATP in cell lysate and to verify cell viability in endpoint
assays,94 however, an experiment aiming to find specific time points would have to be a real-time
assay. Vrana et. al (2014) used sets of simple cell-based real-time assays in combination with
mathematical loops (accounting for aerobic and anaerobic energy metabolism) to estimate the
relative intracellular ATP concentration and therefore define the cell’s metabolic energy state.112
Extracellular oxygen consumption and intracellular NADH were measured kinetically for 24 hours
and the data fed into the following expression to calculate theoretically available energetic
phosphate:
𝐼𝑓 6[𝑂2 ]𝑠𝑎𝑚𝑝𝑙𝑒 − 2 [𝑁𝐴𝐷𝐻]𝑠𝑎𝑚𝑝𝑙𝑒 > 0
𝑇ℎ𝑒𝑛 𝑃𝑂4 =

6 [𝑂2 ]𝑠𝑎𝑚𝑝𝑙𝑒 − 2[𝑁𝐴𝐷𝐻]𝑠𝑎𝑚𝑝𝑙𝑒
4

Else PO4 =

[NADH]sample
4

In theory, the concept can be expanded to eventually calculate the actual concentration of ATP per
cell, using two cell based assays, one to monitor cell density in real time (for example RealTimeGlo™), and another one to measure ATP at distinct endpoints (for example CellTiter-Glo® 2.0).
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Both of these assays are based on a bioluminescent signal, which provides the option to run
experiments in white or black (if multiplexed with fluorescence based assays) 96 well plates and
conveniently obtain data from a plate reader or luminometer.
RealTime-Glo™, for example, has been used to validate cellular health in tumor resistance
experiments,113 investigate the cytotoxicity of bacterial biofilms from wound dressings,114 or study
glucose uptake in a multiplexed assay.115 The basis of the kit is the conversion of a luciferase
prosubstrate (identity proprietary to Promega) into an active luciferase substrate if taken up into a
viable cell. The reducing environment inside the cell facilitates conversion, the substrate exits the
cell into the medium where it causes luminescence through the interaction with luciferase.116 This
way, the signal correlates with active metabolism inside a cell, or put differently, with the
production of reducing molecules, such as NADH or FAD, and the manufacturers claim a linear
increase in signal with cell density.117 Since the substrate is used up by the luciferase, the signal
does not compound over time, which increases the accuracy of real-time measurements and
provides a big advantage over conventional cell viability assays, such as Calcein AM, in addition
to the nontoxic nature of the RealTime-Glo™ reagents. With this assay, it would be possible to
determine the cell number over a given exposure time, granted a standard curve of known densities
would be prepared and measured right before the kinetic measurement, ideally in the same plate.
Then, available energetic phosphate/cell could be estimated:
available PO4 =

PO4
cell density

The second assay, in varying version of the product, has been employed by several studies to
measure cell viability.84,113,118–120 It can also be used to estimate cell density,121 or just simply
measure the content of ATP itself,122 since the assay is based on the reaction of ATP with the
substrate luciferin, which results in a bioluminescent signal directly correlated with the
concentration of the energy carrier inside a cell. This can be used to compare the estimated
available energetic phosphate, to the actual available triphosphate nucleotide. CellTiter-Glo® 2.0
features a solution-mix that contains cell lysis buffer and luciferin as assay reagent. With this
solution, the separate cell lysis step and the consecutive centrifugation to obtain ATP in just the
lysate is eliminated and the relative amount of ATP can be directly measured in the 96 well reaction
plate. A calibration curve of known amounts of analyte can add the important quantitative aspect.
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Since the assay is destructive and only allows for endpoint measurements, specific time points
(such as six, twelve, and 24 hours for a 24-hour kinetic experiment) should be chosen to measure
definite amounts of adenosine triphosphate. The real ATP can then be compared with the estimated
concentration at the same time point, a correction factor can be calculated, and finally it should be
possible to convert the entire 24 hour estimated data into real ATP/cell. Graphic visualization in a
contour plot heat map and calculation of bifurcation points112 can aid in the identification of critical
time points of changes in energetic metabolism.

4.2. Resolve Metabolic Switches in Cellular Energy Metabolism
To understand the fundamental events that change a cell’s behavior after exposure to a xenobiotic,
several questions need to be addressed: If the cell increases ATP production, which pathways are
increased in activity? Are other pathways decreased in activity? If the cell decreases ATP
production, is it bound to die shortly after or does it stay in a lower energetic state and survives?
With respect to resveratrol and its hormetic character, two cellular mechanism are of interest
especially when it comes to hormesis: autophagy and apoptosis.
Once critical time points are identified, experiments should focus on endpoint assays at these times
points to study changes in certain signaling markers. As it is still unclear if common pathways
cause hormetic behavior, such as apoptosis and autophagy, or if a compound triggers its own
profile of distinct beneficial processes inside the cell, several factors could and should be studied.
Kits that label initiator and effector caspases are widely available, as well as antibodies to quantify
Atg, which should give a good understanding of the downstream effects for the pathways of
autophagy and apoptosis. Additionally, signaling associated with nutrient sensing molecules, such
as mTOR, AMPK, Ca2+ and SIRT1 can provide an insight into the metabolic side, whether
metabolism shifts towards catabolic, energy-yielding processes or conserves energy, for example.
The change in redox environment inside the cell would be a useful indicator to measure and would
most likely support the theory that hormesis is a phenomenon based on compound-specific cellular
effects.
Besides expanding the in-depth study of resveratrol, the general experimental concepts can easily
be adapted to other substances, such as sulforaphane (see Appendix A).
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Appendix A - Hormetic Behavior of Sulforaphane

In addition to the compounds covered in the main text, sulforaphane was also screened for its
hormetic behavior in the same cell model (HepG2).

Figure A-1| Chemical Structure: Sulforaphane.

Over the past few years, sulforaphane has received a decent amount of scientific attention. The
compound is an isothiocyanate and a product of an enzymatic hydrolysis of glucoraphanin, a
substance commonly found in cruciform vegetables, the most recognized being broccoli.123–125 The
enzyme (myrosinase) responsible for the release of sulforaphane is found right in the vegetable
itself, but can also be found in human colon microbiota. Among a plethora of beneficial effects, it
has been found to increase cell proliferation and angiogenesis,126 for example, and to have
antioxidant and anti-inflammatory traits while displaying the characteristic biphasic effects of a
hormetin: Cytoprotective and proliferative effects of sulforaphane have been ascribed to
concentration levels below 10 µM for several cell lines, including HepG2;118,126 higher levels
though appear to decrease cell proliferation and induce apoptosis.118,127 Park et al. (2007) found
an increase in pro-apoptotic Bax expression and a simultaneous decrease in Bcl-2 and Bcl-XL
expression (anti-apoptotic factors) after HepG2 cells were exposed to sulforaphane,127 while
Zou et al. (2017) attribute the onset of apoptosis to endoplasmic reticulum stress as they observed
increased expression of Bip, Bid, XBP-1, CHOP, as well as caspase-12.128 The compounds
antioxidant effect stems from the release of nuclear factor erythroid 2-related factor 2 (Nrf2) from
the Keap1/Cul3/Rbx1/E3 complex* upon binding of sulforaphane.123,126 Liberated Nrf2 induces
expression of superoxide dismutase 1 (SOD1) and catalase129 in the nucleus, two major antioxidant
enzymes. A wide range of scientific publication suggests that sulforaphane also increases phase II
detoxification, especially with respect to carcinogens,130 through an increase in glutathione
A complex formed by the noncovalent association of these four peptides: Kelch-like ECH-associated protein 1
(Keap1), Cullin 3 (Cul3), ring box 1 (Rbx1), and ubiquitin ligase E3 (E3). It serves as a redox sensing formation in
the cytosol that binds Nrf2 under low oxidative cellular conditions.123
*
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S - transferase (GST), glutathione levels in general, thioredoxins, as well as quinone
reductase,118,130–132 and reduces phase I metabolism,123,133 which can decrease a xenobiotics
harmful potential.

Effects on Metabolic Activity
Materials and Methods
HepG2 cells were exposed to sulforaphane in varying concentrations (0.01 – 500 µM) for 24 hours.
Sulforaphane was acquired from Cayman Chemical Company. HepG2 (human hepatocellular
carcinoma-derived) cells were cultured in Gibco® RPMI-1640 Medium without L-glutamine,
supplemented with 5% FBS, 2% penicillin and streptomycin, and 1% L-glutamine, and maintained
at 37 °C in humidified, 5% CO2 atmosphere. Before lifting, cells were washed twice with cold
phosphate buffered saline. A stock solution of 50 mM was prepared in DMSO. 100X dosing
solutions were freshly mixed by serial dilution of the stock solution in DMSO. These were
subsequently diluted 100-fold in culture media. The dosing solutions had a final DMSO
concentration of 1%. Cells were plated in a clear 96 well plate at a density of 60x103 cells/well in
100 µL media and allowed to reattach for 24 hours. At this point, spent media was removed and
100 uL fresh media supplied, which contained the respective concentration of sulforaphane.
The MTT reagent was prepared by dissolving 3,[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide in PBS to a concentration of 5 mg/mL. The detergent was a solution of 10%
SDS in DMSO containing 0.6% glacial acetic acid. Briefly, after 24-hour exposure, 20 µL of MTT
reagent were added to each well. After 6 hours of incubation at 37 °C, 100 µL/well were dispensed
and the plates allowed to rest for 5 minutes before they were shaken on an orbital shaker at 500 rpm
for 5 minutes. Absorbance was measured immediately after at 570 nm wavelength on a Fluostar
Optima (BGM Labtech, Germany). Controls for this assay included untreated 1% DMSO vehicle
controls, as well as blank controls without cells at each concentration for background absorbance,
since sulforaphane showed an increased absorbance with increased concentration, especially upon
addition of the MTT reagent.
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Results and Conclusion
After 24 hours of exposure to sulforaphane (0.01 – 500 µM), a significant increase in metabolic
activity is seen at 5 µM and 10 µM compared to the untreated control (Figure A-1, Table A-1). A
slight increase is noticeable, although not statistically significant, starting from 0.1 µM and
steadily rising to 5 µM. By that point, activity had increased by 53% in the mean. After that, the
effect receded: 10 µM still result in a 38% higher-than-control activity, 25 µM tends to be less
than 20% higher. The response to 50 µM changed significantly compared to 25 µM, where
metabolic activity already decreased down to 70% of the control value. Half of the metabolic
activity was lost at 70 to 100 µM. Virtually no metabolic activity (3%) was observed when cells
were treated with 200 µM of sulforaphane, or more.
Sulforaphane

rel. Signal Metabolic Activity

2.0

Metabolic Activity

1.5

1.0

0.5

0.0
0.0001

0.001

0.01

0.1

1

10

100

Conc [M]

Figure A-2| Metabolic activity after 24-hour exposure to sulforaphane.
HepG2 cells were exposed to varying concentrations of sulforaphane for 24 hours. Effects on
metabolic activity were assessed using MTT. Data shown represent the mean and the standard
error of the mean from six independent experiments. Experimental values were measured in
triplicate.
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Table A-1| Summary of statistically significant changes in metabolic activity by sulforaphane concentration
compared to untreated vehicle controls and previous concentrations.
Compared to Untreated Vehicle Control

Metabolic Activity

Compared to Previous Concentration
#

Concentration [µM]

* p≤0.05
** p≤0.01
*** p≤0.001

Concentration [µM]

p≤0.05
p≤0.01
### p≤0.001

5

***

50

###

10

*

70 - 500

***

##

These results confirm previously reported observations119,128,130,134 and recommend sulforaphane
as a prime subject for further investigation in plasma membrane integrity measurements and realtime experiments. However, data shown and discussed in Appendix B draws doubt on the just
presented data and the reliability of the performed experiments under the chosen experimental
conditions.
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Appendix B - Impact of Cell Population and Instrumentation

The data presented in the main text was uniformly acquired in the same laboratory, using the same
cell culture reagents, the same equipment, and instrumentation. However, comparative data for
epigallocatechin gallate, quercetin, and resveratrol was also acquired in a laboratory at the Fulda
University of Applied Sciences with a different population of HepG2 cells, different reagents, and
instrumentation. Instrument bias and speculations on the source of cell population variability have
been discussed in literature before,135–137 the following is a comparison of the data gathered in both
laboratories, which impressively shows the impact of cell population and instrumentation on
research outcomes.

Methods and Materials
Materials and methodology are described in detail in the main text for the data labeled “West
Virginia University”. Data labeled with “Fulda U.o.A.Science” was acquired as presented below:
Materials
All materials were acquired from VWR, unless otherwise specified. Quercetin, (-)epigallocatechin gallate, and trans-resveratrol, were obtained from Cayman Chemical Company.
Cell Culture
HepG2 (human hepatocellular carcinoma-derived) cells were cultured in Gibco® RPMI-1640
Medium without L-glutamine, supplemented with 5% FBS, 2% penicillin and streptomycin, and
1% L-glutamine, and maintained at 37 °C in humidified, 5% CO2 atmosphere. Before lifting, cells
were washed twice with cold phosphate buffered saline.
MTT Assay
Cell viability assays were performed using these solutions: The MTT reagent was prepared by
dissolving

3,[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium

bromide

in

PBS

to

a

concentration of 5 mg/mL. The detergent was a solution of 10% SDS in DMSO containing 0.6%
concentrated acetic acid. Briefly, after 24-hour exposure, 20 µL of MTT reagent were added to
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each well. After 6 hours of incubation at 37 °C, 100 µL/well were dispensed and the plates allowed
to rest for 5 minutes before they were shaken on an orbital shaker at 500 rpm for 5 minutes.
Absorbance was measured immediately after at 570 nm wavelength on a Fluostar Optima (BGM
Labtech, Germany). All other aspects were similar to the procedures laid out in the main text.

Results and Discussion

Epigallocatechin Gallate

Quercetin

2.5

2.5

Fulda U.o.A.Science

Fulda U.o.A.Science

West Virginia University

West Virginia University
2.0

rel. Signal Metabolic Activity

rel. Signal Metabolic Activity

2.0

1.5

1.0

0.5

0.0
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0.001

0.01

0.1

1

10

100

Conc [M]
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Figure B-1| Comparison of metabolic activity data after
exposure of HepG2 cells to epigallocatechin gallate, quercetin,
and resveratrol from two different laboratories with varying
cell population, instrumentation, and assay reagents.

Resveratrol
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1

10

100

HepG2 cells were exposed to varying concentrations of
epigallocatechin gallate (top left), quercetin (top right), and
resveratrol (bottom) for 24 hours. Effects on metabolic activity
were assessed using MTT. Data shown represent the mean and the
standard error of the mean from six independent experiments for
the Fulda U.o.A.Science dataset and four independent
experiments for the West Virginia University dataset.
Experimental values were measured in triplicate.

Table B-1| Comparative summary of statistically significant changes in metabolic activity by compound
concentration compared to untreated vehicle controls and previous concentrations.
Compared to Untreated Vehicle Control
Metabolic Activity

Concentration [µM]

* p≤0.05
** p≤0.01
*** p≤0.001

Compared to Previous Concentration
#

Concentration [µM]

p≤0.05
p≤0.01
### p≤0.001
##

Epigallocatechin Gallate
West Virginia University

Fulda U.o.A.Science

No statistically significant changes
5
10 & 25
100
300
400 & 500

No statistically significant changes

**
***
**
*
***

50

#

Quercetin
West Virginia University
Fulda U.o.A.Science

No statistically significant changes
200 & 400
500
600
800

No statistically significant changes

*
**
***
**

2000

##

Resveratrol
West Virginia University

500

***

No statistically significant changes

Fulda U.o.A.Science

10 & 400
500

**
***

No statistically significant changes

Metabolic activity in response to a 24-hour exposure of three compounds (epigallocatechin gallate,
quercetin, and resveratrol) was investigated in two laboratories, one at West Virginia University,
the other one at Fulda University of Applied Science (Fulda U.o.A.Science). Cell culture stock
and reagents, assay conditions, and instrumentation varied between the two laboratories, which
was clearly observable in the acquired data.
In the case of epigallocatechin gallate, the mean values from Fulda describe a very interesting
behavior: Metabolic activity did not change significantly up to 5 µM compared to vehicle control,
but at 5 µM activity increased by 51% in the mean and even by 63% and 61% at 10 µM and 25 µM,
respectively. 50 µM did not change the response significantly compared to vehicle controls, but
compared to the previous concentration of 25 µM the signal decreased markedly. 100 µM again
boosted metabolic activity 53% above the control level. Concentrations higher than 100 µM then
continuously impeded metabolic response, for example down to about 50% of the control value
from 300 µM exposure and less than 20% for the highest exposure of 500 µM.
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The cellular response was not reproducible in the American laboratory. High variability in the
independent experiments drove the standard error of the mean, therefore no statistically significant
changes in metabolic activity were found. However, a slight trend of increased metabolic activity
past 100 µM was observed, although the signal did not decrease below control values even at the
highest dose.
Similarly, trends from resveratrol exposure shifted and were not reproducible. While the data from
Fulda point to a statistically significant peak increase in metabolic activity at 10 µM (67%) and a
decrease of activity starting at 70 µM, data from West Virginia University does not show a
significantly increased response until 50 µM and 100 µM (38% and 57%, respectively) and a
decreased activity starting between 200 and 400 µM. Only 50 µM and 500 µM evoked a
comparable cellular metabolic activity.
The shift in concentration response was somewhat less pronounced when cells were exposed to
Quercetin. Concentrations between 200 µM and 1000 µM increased the metabolic activity by 50%
to almost 100% of the vehicle control values. Lower concentrations in the range of 0.1 µM to
10 µM also strengthened metabolism noticeably up to 40%, but not statistically significantly.
Compared to that, no statistically significant changes were observed in the experiments from West
Virginia University, especially at higher concentrations, due to exceptionally large standard errors.
A small trend of increased metabolic activity could be inferred at 200 µM. Smaller doses from
0.01 µM to 10 µM demonstrated no noticeable difference.
The data provided is a prime example of the impact of instrumentation and reagent/procedure
consistency on experimental outcome. There is no method to determine which laboratory results
are closest to the actual cellular behavior, unless more independent trials are performed. Even then
it is not guaranteed that the results will converge, as the genetic and behavioral variation between
separate populations of the same cell line can be, as demonstrated, quite large. It would be
interesting to see how large the difference in results would be with the same protocols, chemicals,
and instrumentation to assess the true impact of cell population. Single cell measurements might
be a better way to study the exact effects of hormetic compounds, since it has been shown before
that actual signaling events can be significantly different from what cell population studies
suggest.12
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